Tellgen Corporation (300642.SZ) Subsidiary Obtains Medical Device Registration Certificates

Stock News
Dec 19, 2025

Tellgen Corporation (300642.SZ) announced that its wholly-owned subsidiary, Shanghai Tellgen Diagnostics Technology Co., Ltd., recently obtained five medical device registration certificates issued by the Shanghai Medical Products Administration.

The approved products include: - Anti-dsDNA Antibody IgG Detection Kit (Flow Fluorescence Luminescence Method) - Anti-C1q Antibody IgG Detection Kit (Flow Fluorescence Luminescence Method) - Anti-M2-3E Antibody IgG Detection Kit (Flow Fluorescence Luminescence Method) - Antiphospholipid Syndrome IgA Antibody Detection Kit (Flow Fluorescence Luminescence Method) - Anti-Nucleosome Antibody IgG Detection Kit (Flow Fluorescence Luminescence Method).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10